Overview

Raltitrexed Concurrent With Radiotherapy for Elderly Chinese Patients With Squamous Cell Carcinoma of Esophagus

Status:
Active, not recruiting

Trial end date:
2022-03-15

Target enrollment:

Participant gender:

Summary

Concurrent chemoradiotherapy is one of the curative options for esophageal squamous cell carcinoma. We evaluated the efficacy and toxicity of raltitrexed with concurrent radiotherapy in elderly patients with esophageal cancer.

Phase:

Phase 2

Details

Lead Sponsor:

Huai'an First People's Hospital

Treatments:

Raltitrexed